{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:53:20Z","timestamp":1777532000477,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1007\/s11886-000-0081-7","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T23:57:49Z","timestamp":1179619069000},"page":"274-279","source":"Crossref","is-referenced-by-count":26,"title":["The role of C-reactive protein in cardiovascular disease risk"],"prefix":"10.1007","volume":"2","author":[{"given":"Michelle A.","family":"Albert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"81_CR1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","volume":"144","author":"LH Kuller","year":"1996","unstructured":"Kuller LH, Tracy RP, Shaten J, Meilahn EN: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiology 1996, 144:537\u2013547.","journal-title":"Am J Epidemiology"},{"key":"81_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973\u2013979. A prospective study in initially healthy physicians demonstrating a 44% reduction cardiovascular risk with the use of aspirin in those participants with elevated CRP concentrations.","journal-title":"N Engl J Med"},{"key":"81_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"W Koenig","year":"1999","unstructured":"Koenig W, Sund M, Frohlich M, et al.: C-reactive protein, a sensitive marker of coronary heart disease in initially healthy middle aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999, 99:237\u2013242.","journal-title":"Circulation"},{"key":"81_CR4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Buring JE, Shih J, et al.: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731\u2013733.","journal-title":"Circulation"},{"key":"81_CR5","doi-asserted-by":"crossref","unstructured":"Tracy RP, Lemaitre RN, Psaty BM, et al.: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997, 1121\u20131127.","DOI":"10.1161\/01.ATV.17.6.1121"},{"key":"81_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Hennekens CH, Rifai N, et al.: Hormone replacement therapy and increased concentration of C-reactive protein. Circulation 1999, 100:713\u2013716.","journal-title":"Circulation"},{"key":"81_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M Visser","year":"1999","unstructured":"Visser M, Bouter LM, McQuillan GM, et al.: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131\u20132135. A populational study demonstrating that CRP levels are elevated in overweight individuals, suggesting a possible inflammatory component to obesity and a link to cardiovascular disease.","journal-title":"JAMA"},{"key":"81_CR8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1046\/j.1523-1755.1999.00422.x","volume":"55","author":"P Stenvinkel","year":"1999","unstructured":"Stenvinkel P, Heimburger O, Paultre F, et al.: Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1889\u20131911.","journal-title":"Kidney Int"},{"key":"81_CR9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Rifai N, Pfeffer MA, et al.: Long term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999, 100:230\u2013235. A prospective study demonstrating that statin therapy may have anti-inflammatory activity in cardiovascular disease.","journal-title":"Circulation"},{"key":"81_CR10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.CIR.100.11.1148","volume":"100","author":"P Libby","year":"1999","unstructured":"Libby P, Ridker PM: Novel inflammatory markers of coronary risk theory versus practice. Circulation 1999, 100:1148\u20131150.","journal-title":"Circulation"},{"key":"81_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115\u2013126.","journal-title":"N Engl J Med"},{"key":"81_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0092-8674(90)90230-C","volume":"62","author":"L Osbourne","year":"1990","unstructured":"Osbourne L: Leucocyte adhesion to endothelium in inflammation. Cell 1990, 62:3\u20136.","journal-title":"Cell"},{"key":"81_CR13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00019501-199403000-00003","volume":"5","author":"M Navab","year":"1994","unstructured":"Navab M, Hama SY, Nguyen TB, Fogelman AM: Monocyte adhesion and transmigration in atherosclerosis. Coron Artery Dis 1994, 5:198\u2013204.","journal-title":"Coron Artery Dis"},{"key":"81_CR14","first-page":"119","volume":"9","author":"HC Stacy","year":"1989","unstructured":"Stacy HC: Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989, 9:119\u2013132.","journal-title":"Arteriosclerosis"},{"key":"81_CR15","first-page":"II38","volume":"82","author":"MJ Davis","year":"1990","unstructured":"Davis MJ: A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990, 82:II38-II46.","journal-title":"Circulation"},{"key":"81_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillet","year":"1930","unstructured":"Tillet WS, Francis T: Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930, 52:561\u2013571.","journal-title":"J Exp Med"},{"key":"81_CR17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","volume":"45","author":"N Rifai","year":"1999","unstructured":"Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136\u20132141.","journal-title":"Clin Chem"},{"key":"81_CR18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","volume":"100","author":"M Cushman","year":"1999","unstructured":"Cushman M, Legault C, Barrett-Connor E, et al.: Effect of postmenopausal hormones on inflammation sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) study. Circulation 1999, 100:717\u2013722. Randomized trial that demonstrates elevated inflammatory markers such as CRP are associated with the use of HRT.","journal-title":"Circulation"},{"key":"81_CR19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Hennekens CH, Rifai N, et al.: Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999, 100:713\u2013716.","journal-title":"Circulation"},{"key":"81_CR20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0037-1614600","volume":"81","author":"WM Baal van","year":"1999","unstructured":"van Baal WM, Kenemans P, van der Mooren MJ, et al.: Increased C-reactive protein levels during short term hormone replacement therapy in healthy postmenopausal women. Thromb Haemost 1999, 81:925\u2013928.","journal-title":"Thromb Haemost"},{"key":"81_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S, Grady D, Bush T, et al.: for the Heart and Estrogen\/ progestin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280:605\u2013613. First randomized trial to show an early increase in cardiovascular events with the use of HRT.","journal-title":"JAMA"},{"key":"81_CR22","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/diacare.22.12.1971","volume":"22","author":"ES Ford","year":"1999","unstructured":"Ford ES: Body mass index, diabetes and C-reactive protein among U.S. adults. Diabetes Care 1999, 22:1971\u20131977.","journal-title":"Diabetes Care"},{"key":"81_CR23","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","volume":"95","author":"PA Kern","year":"1995","unstructured":"Kern PA, Saghizadeh M, Ong JM, et al.: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995, 95:2111\u20132119.","journal-title":"J Clin Invest"},{"key":"81_CR24","first-page":"3052","volume":"80","author":"A Purhoit","year":"1995","unstructured":"Purhoit A, Ghilchik MW, Duncan L, et al.: Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995, 80:3052\u20133058.","journal-title":"J Clin Endocrinol Metab"},{"key":"81_CR25","first-page":"847","volume":"83","author":"V Mohamed-Ali","year":"1998","unstructured":"Mohamed-Ali V, Goodrick S, Rawesh A, et al.: Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor in vivo. J Clin Endocrinol Metab 1998, 83:847\u2013850.","journal-title":"J Clin Endocrinol Metab"},{"key":"81_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","volume":"97","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al.: Plasma concentration of C-reactive protein and the risk of developing peripheral vascular disease. Circulation 1998, 97:425\u2013428.","journal-title":"Circulation"},{"key":"81_CR27","first-page":"1108","volume":"99","author":"JD Curb","year":"1999","unstructured":"Curb JD, Abbott RD, Rodriguez BL, et al.: The relationship of C-reactive protein to the incidence of thromboembolic stroke: abstract of the 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention 1999. Circulation 1999, 99:1108.","journal-title":"Circulation"},{"key":"81_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(99)00162-8","volume":"147","author":"CR Canova","year":"1999","unstructured":"Canova CR, Courtin C, Reinhart WH: C-reactive protein in cerebro-vascular events. Atherosclerosis 1999, 147:49\u201353.","journal-title":"Atherosclerosis"},{"key":"81_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","volume":"321","author":"Steering Committee of the Physicians' Health Study Research Group","year":"1989","unstructured":"Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989, 321:129\u2013135.","journal-title":"N Engl J Med"},{"key":"81_CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Rifai N, Pfeffer MA, et al.: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999, 100:230\u2013235.","journal-title":"Circulation"},{"key":"81_CR31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Burin JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836\u2013843. Prospective trial showing that hs-CRP improves screening for cardiovascular disease when added to lipid levels.","journal-title":"N Engl J Med"},{"key":"81_CR32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","volume":"97","author":"M Aikawa","year":"1998","unstructured":"Aikawa M, Rabkin E, Okada Y, et al.: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. A potential mechanism of lesion stabilization. Circulation. 1998, 97:2433\u20132444.","journal-title":"Circulation."},{"key":"81_CR33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2125.1994.tb04392.x","volume":"38","author":"S Keidar","year":"1994","unstructured":"Keidar S, Aviram M, Maor I, et al.: Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies. Br J Clin Pharmacol 1994, 38:513\u2013519.","journal-title":"Br J Clin Pharmacol"},{"key":"81_CR34","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.ATV.15.11.1938","volume":"15","author":"M Shiomi","year":"1995","unstructured":"Shiomi M, Ito T, Tasukada T, Yata T, et al.: Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995, 15:1938\u20131944.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"81_CR35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0021-9150(96)05851-0","volume":"124","author":"WP Castelli","year":"1996","unstructured":"Castelli WP: Lipids, risk factors and ischemic heart disease. Atherosclerosis 1996, 124:S1-S9.","journal-title":"Atherosclerosis"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-000-0081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-000-0081-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-000-0081-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:55:42Z","timestamp":1587534942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-000-0081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1007\/s11886-000-0081-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}